Table 2.
Comorbidities among the study cohort.
| mTKA (n = 68) | NAVIO (n = 76) | CORI (n = 71) | p Value | |
|---|---|---|---|---|
| Comorbidity, n (%) | 57 (83.8%) | 49 (64.5%) | 51 (71.8%) | 0.9733 |
| Hypertension | 16 (23.5%) | 18 (23.7%) | 19 (26.8%) | 0.0782 |
| Arrhythmias | 5 (7.4%) | 2 (2.7%) | 0 | 0.8793 |
| Hypothyroidism | 5 (7.4%) | 3 (3.9%) | 6 (8.5%) | 0.0812 |
| Diabetes mellitus | 13 (19.1 %) | 16 (21.1%) | 11 (15.5%) | 0.0765 |
| Asthma | 3 (4.4%) | 1 (1.3%) | 0 | 0.5210 |
| Depression | 3 (4.4%) | 0 | 1 (1.4%) | 0.9854 |
| Systemic lupus erythematosus | 1 (1.5%) | 0 | 2 (2.8%) | 0.9982 |
| Rheumatoid arthritis | 3 (4.4%) | 2 (2.7%) | 5 (7%) | 0.3965 |
| Gout | 7 (10.3%) | 4 (5.3%) | 5 (7%) | 0.2135 |
| Psoriatic arthritis | 1 (1.5%) | 3 (3.9%) | 2 (2.8%) | 0.0754 |